These success, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,two support the strategy of targeting ACKR3 as a unique method to modulate the opioid technique, which could open up new therapeutic avenues for opioid-related A